Enjeux de l’utilisation des psychotropes dans le cadre de la pandémie au SARS-Cov-2

French recommendations have been proposed for psychotropics use and possible adaptations during the SARS-CoV-2 epidemic. Between uncertainties linked to the lack of data and speculations about possible benefits of psychotropics against the coronavirus, we propose here elements allowing to base the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Javelot, H., Llorca, P.-M., Meyer, G., Fossati, P., Haffen, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: L'Encéphale, Paris. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177137/
https://www.ncbi.nlm.nih.gov/pubmed/32360037
http://dx.doi.org/10.1016/j.encep.2020.04.009
Descripción
Sumario:French recommendations have been proposed for psychotropics use and possible adaptations during the SARS-CoV-2 epidemic. Between uncertainties linked to the lack of data and speculations about possible benefits of psychotropics against the coronavirus, we propose here elements allowing to base the pharmacotherapeutic decisions potentially useful in Covid+ patients with psychiatric disorders.

Ejemplares similares